Cite
HARVARD Citation
Vora, P. et al. (n.d.). PS2 - 172 Preclinical Validation of a Novel CD33/CD3 Bispecific T-Cell Engager (BiTE) Antibody to Target Patient-Derived Glioblastoma Cells. Canadian journal of neurological sciences. pp. S13-S14. [Online].